F16.921
Hallucinogen use, unspecified with intoxication with delirium
Clinical Classification Guidelines
Inclusion Terms
- Other hallucinogen intoxication delirium
Medical Intelligence & Overview
ICD-10 Code F16.921 refers to cases where individuals experience intoxication from hallucinogens, leading to delirium. Hallucinogens are substances that alter perception, mood, and various cognitive processes. When used, these drugs can sometimes cause severe mental state changes, including delirium—a state characterized by confusion, disorientation, and hallucinations. This guide aims to provide a clear overview of this condition, including its causes, symptoms, diagnosis, and general management principles.
Causes & Symptoms
Clinical Causes: Use of hallucinogenic substances such as psilocybin, LSD, DMT, or other similar drugs Combination of hallucinogens with other substances like alcohol or stimulants Underlying mental health conditions that predispose to substance-induced delirium Pre-existing medical conditions affecting liver, kidney, or brain health that elevate risk
Key Symptoms: Altered perceptions and visual or auditory hallucinations Confusion and disorientation about time, place, or identity Agitation or restlessness Mood swings, including paranoia or intense fear Physical signs such as dilated pupils, rapid heartbeat, or sweating Possible loss of coordination or balance
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive medical and psychological assessment, focusing on recent substance use history and current mental state. Healthcare providers may perform blood or urine tests to detect hallucinogens or other substances. Observing the patient's behavior and mental status helps to determine the presence of delirium associated with hallucinogen intoxication. Differential diagnosis is essential to exclude other neurological or psychiatric conditions that might mimic these symptoms.
Treatment Protocols: Management of hallucinogen-induced delirium typically involves supportive care and monitoring. Ensuring a safe environment is crucial to prevent injury, as patients may experience disorientation or agitation. Medical interventions may include sedation in severe cases, hydration, and correction of any metabolic disturbances. Long-term treatment could involve addressing underlying substance use issues, counseling, and mental health support to prevent recurrence.
Clinical Advice & FAQs
Billing Guidance
Is F16.921 a billable ICD-10 code?
Yes, F16.921 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F16.921?
Clinical documentation must specify the nature of Hallucinogen use, unspecified with intoxication with delirium and any associated comorbidities for accurate reporting.
Cite this Clinical Reference